EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
    2.5.1.21 | Adenocarcinoma |
31677963 |
The diagnostic utility of zinc E-box 1 (ZEB1) transcription factor for identification of pulmonary sarcomatoid carcinoma in cytologic and surgical specimens. |
diagnostic usage
therapeutic application
unassigned |
3
2
0 |
| 2.5.1.21 | Carcinoid Tumor |
31677963 |
The diagnostic utility of zinc E-box 1 (ZEB1) transcription factor for identification of pulmonary sarcomatoid carcinoma in cytologic and surgical specimens. |
diagnostic usage
therapeutic application
unassigned |
3
2
0 |
| 2.5.1.21 | Carcinoma |
31677963 |
The diagnostic utility of zinc E-box 1 (ZEB1) transcription factor for identification of pulmonary sarcomatoid carcinoma in cytologic and surgical specimens. |
diagnostic usage
therapeutic application
unassigned |
3
2
0 |
| 2.5.1.21 | Carcinoma, Large Cell |
31677963 |
The diagnostic utility of zinc E-box 1 (ZEB1) transcription factor for identification of pulmonary sarcomatoid carcinoma in cytologic and surgical specimens. |
diagnostic usage
therapeutic application
unassigned |
3
2
0 |
| 2.5.1.21 | Carcinoma, Neuroendocrine |
31677963 |
The diagnostic utility of zinc E-box 1 (ZEB1) transcription factor for identification of pulmonary sarcomatoid carcinoma in cytologic and surgical specimens. |
diagnostic usage
therapeutic application
unassigned |
3
2
0 |
| 2.5.1.21 | Carcinoma, Squamous Cell |
31677963 |
The diagnostic utility of zinc E-box 1 (ZEB1) transcription factor for identification of pulmonary sarcomatoid carcinoma in cytologic and surgical specimens. |
diagnostic usage
therapeutic application
unassigned |
3
2
0 |
| 2.5.1.21 | Neoplasms |
31677963 |
The diagnostic utility of zinc E-box 1 (ZEB1) transcription factor for identification of pulmonary sarcomatoid carcinoma in cytologic and surgical specimens. |
diagnostic usage
therapeutic application
unassigned |
3
2
0 |
| 2.5.1.21 | Breast Neoplasms |
31949508 |
Experimental, Clinical and Morphological Analysis of H-Ras Oncoproteins for Locally Advanced Breast Cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
4 |
| 2.5.1.21 | Neoplasms |
32247731 |
Ultrasounds-mediated 10-seconds synthesis of chalcones as potential farnesyltransferase inhibitors. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
1
4
1
0 |
| 2.5.1.21 | Hepatitis, Autoimmune |
32251961 |
The farnesyltransferase inhibitor tipifarnib protects against autoimmune hepatitis induced by Concanavalin A. |
therapeutic application
unassigned |
4
0 |
